Cree Inc. (NASDAQ: CREE | Quote | Chart | News | PowerRating) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN), and related compounds. It offers light emitting diode (LED), SiC and GaN material, and power and radio frequency (RF) products. The company's LED products include LED chips, LED components, and LED lighting solutions. Its LED chips comprise blue and green devices that are used in backlighting for mobile products, automotive interior lighting, full-color electronic displays, gaming equipment, consumer products, and electronic equipment. The company's LED components include packaged LED products for lighting applications, such as general illumination, portable, architectural, signal, and transportation lighting; and surface mount and through-hole LED products for automotive, signage, gaming, and specialty lighting. It offers LED lighting solutions for construction, retrofit, and renovation projects in residential and commercial applications. Cree provides SiC and GaN wafer and epitaxy material products to corporate, government, and university customers to manufacture products for optoelectronic, microwave, and power switching applications; and SiC crystal materials for gemstone applications. Its power devices are used in power factor correction circuits for power supplies in computer servers and other applications, such as solar inverters. The company's RF devices include transistors for broadband amplifiers and WiMAX applications. It also provides foundry services that allow customers to design RF circuits used in bandwidth communications applications, high-power radar amplifiers, electronic warfare, and wireless infrastructure. Cree operates in Hong Kong, China, the United States, Korea, Japan, Europe, Malaysia, and Taiwan. The company was founded in 1987 and is headquartered in Durham, North Carolina. With 88.1 million shares outstanding and 24.55 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of CREE. According to quarterly data provided by the SEC, there were still 7,510,178 shares of CREE that were failing-to-deliver as of January 23, 2008.
Crocs Inc. (NASDAQ: CROX | Quote | Chart | News | PowerRating) and its subsidiaries design, develop, and manufacture consumer products from specialty resins worldwide. The company primarily offers footwear for men, women, and children under the Crocs brand. It also offers apparel, gear, and accessories, including backpacks and messenger bags, kneepads, gloves, sticks, pants, shin guards, pads, spa pillows, and seats and pads for kayaks and canoes, as well as hockey and lacrosse equipment. The company sells its products through customer store locations, including company-operated kiosks and retail stores; Web stores; sporting goods and department stores; specialty retailers; and sales agents and buying groups. As of December 31, 2007, it operated 29 domestic and international retail stores, 174 domestic and international retail kiosks located in malls and other high foot traffic areas, and 6 outlet stores. The company was founded as Western Brands, LLC in 1999 and changed its name to Crocs, Inc. in 2005. Crocs, Inc. is based in Niwot, Colorado. With 82.84 million shares outstanding and 25.78 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of CROX. According to quarterly data provided by the SEC, there were still 2,441,387 shares of CROX that were failing-to-deliver as of April 14, 2008.
Hansen Natural Corp. (NASDAQ: HANS | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the development, marketing, sale, and distribution of beverages in the United States and Canada. It offers natural sodas, fruit juices and juice drinks, energy drinks and energy sports drinks, fruit juice smoothies and functional drinks, non-carbonated ready-to-drink iced teas, lemonades, juice cocktails, and children's multi-vitamin juice drinks. The company also provides energy drinks under the Monster Energy, Lost Energy, Joker Mad Energy, Unbound Energy, and Ace brand names, as well as the Rumba brand energy juice. In addition, it markets and sells Java Monster non-carbonated dairy-based coffee drinks; natural sodas, premium natural sodas with supplements, organic natural sodas, seltzer waters, sports drinks, and energy drinks the under Blue Sky brand name; and non-carbonated lightly flavored energy waters under the Hansen's brand name. Further, the company provides vitamin and mineral drink mixes in powdered form under the Fizzit brand name. Its customers include retail grocery and specialty chains, wholesalers, club stores, drug chains, mass merchandisers, convenience chains, full service beverage distributors, health food distributors, and food service customers. The company was founded in 1985 and is based in Corona, California. With 92.34 million shares outstanding and 29.6 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of HANS. According to quarterly data provided by the SEC, there were still 1,106,673 shares of HANS that were failing-to-deliver as of June 17, 2008.
Lipid Sciences Inc. (OTC: LIPD | Quote | Chart | News | PowerRating) a development-stage biotechnology company, engages in the research and development of products and processes to treat medical indications, such as cardiovascular diseases and viral infections in which lipids or fat components play a key role. Its technologies are based on a patented process that selectively removes lipids, such as cholesterol from targeted lipoproteins or viruses circulating in blood plasma without disrupting the nontargeted plasma proteins function. The company focuses on applications of its technologies in two areas, including cardiovascular disease using its high-density lipoproteins (HDL) therapy platform, and viral infections using its viral immunotherapy platform. The HDL therapy platform includes HDL selective delipidation, as well as HDL mimetic peptides, which consists of a sequence of amino acids that mimic the critical functional characteristics of Apolipoprotein A-I, a key protein component of HDL. This platform focuses on developing treatments for the reversal of atherosclerosis, which is the primary cause of heart attacks, strokes, and peripheral vascular disease. The viral immunotherapy platform focuses on the removal of lipid coatings from lipid-enveloped viruses and other lipid-containing infectious agents, such as human immunodeficiency virus, hepatitis B, and hepatitis C by the application of lipid sciences' delipidation technologies. It has a collaborative research and license agreement with Elanco Animal Health to research, develop, manufacture, and sell immunological products for animal health applications. The company, formerly known as NZ Corporation, was founded in 1908 and is headquartered in Pleasanton, California. On October 3, 2008, Lipid Sciences Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California, Oakland. With 37.13 million shares outstanding and 37,800 shares declared short as of September 2008, there is no longer a failure to deliver in shares of LIPD. According to quarterly data provided by the SEC, there were still 310,448 shares of LIPD that were failing-to-deliver as of November 22, 2006.
Solarfun Power Holdings Co. Ltd. (NASDAQ: SOLF | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the development, manufacture, and sale of photovoltaic (PV) cells and PV modules. It offers monocrystalline and multicrystalline silicon cells and modules, monocrystalline ingots, and raw materials. The company sells its products directly and through third party distributors to solar power system integrators and distributors. Solarfun Power Holdings operates primarily in the People's Republic of China, Germany, Spain, and Italy. The company was founded in 2004 and is headquartered in Qidong, the People's Republic of China. With 48 million shares outstanding and 8.45 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of SOLF. According to quarterly data provided by the SEC, there were still 2,724,521 shares of SOLF that were failing-to-deliver as of April 10, 2008.
Zoltek Companies Inc. (NASDAQ: ZOLT | Quote | Chart | News | PowerRating) through its subsidiaries, develops, manufactures, and markets carbon fibers and technical fibers in the United States. Its carbon fibers are used in a range of commercial products, as well as in reinforcement material in composites, carbon fiber composite products, and filament winding equipment used in the composite industry. The company's technical fiber is a stabilized and oxidized acrylic fiber used in flame and heat-resistant applications; and oxidized acrylic fibers are used to manufacture aircraft brake pads for heat/fire barrier applications. In addition, it sells filament winding and pultrusion equipment used in the production of large volume composite parts. The company was founded in 1975 and is based in St. Louis, Missouri. With 34.31 million shares outstanding and 6.27 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of ZOLT. According to quarterly data provided by the SEC, there were still 1,394,823 shares of ZOLT that were failing-to-deliver as of June 23, 2008.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index